Can interpectoral nodes be sentinel nodes?

American Journal of Surgery

Volumn 178, Issue 5, 1999, Pages 360-361

  Bale, Asha ^a   Gardner, Bernard ^a   Shende, Manisha ^a   Fromowitz, Frank ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; LYMPH NODE METASTASIS; PECTORALIS MAJOR MUSCLE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK;

ADULT; AGED; AXILLA; BIOPSY; BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; SENSITIVITY AND SPECIFICITY;

EID: 0033429249     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(99)00199-3     Document Type: Article

References (15)

1. Cady B. Lymph node metastasis - indicators, but not governors of survival. Arch Surg. 119:1984;1067.
2. Fisher E.R., Anderson S., Redmon C., Fisher B. Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation pathologic findings from NSABP protocol B-06 . Semin Surg Oncol. 8:1992;161-166.
3. Whelan T., Clark R., Roberts R., et al. Ipsilateral breast tumor recurrence post lumpectomy is predictive of subsequent mortality results from a randomized trial . Int J Rad Oncol Biol Phys. 30:1994;11-16.
4. Fortin A., Larochelle M., Laverdiere J., et al. Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol. 17:1999;101-109.
5. Gardner B., Feldman J. Are positive axillary nodes in breast cancer markers for incurable disease? Ann Surg. 218:1993;270-278.
6. Harris J.R., Osteen R.T. Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat. 5:1985;17-21.
7. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. NEJM. 337:1997;949-955.
8. Ragaz J., Jackson S.M., Le N., et al. Adjuvant radiotherapy and chemotherapy in node positive premenopausal women with breast cancer. NEJM. 337:1997;956-962.
9. Velez-Garcia E., Carpenter J.T., Moore M., et al. Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes a South-Eastern Cancer Study Group (SEG) trial . Eur J Cancer. 28A:1992;1833-1837.
10. Dixon J.M., Dobie V., Chetty U., et al. The importance of interpectoral nodes in breast cancer. Eur J Cancer. 29A:1993;334-336.
11. Senofsky G.M., Moffat F.L., Davis K., et al. Total axillary lymphadenectomy in the management of breast cancer. Arch Surg. 126:1991;1336-1342.
12. Chandawarker R.Y., Shinde S.R. Interpectoral nodes in carcinoma of the breast requiem or resurrection . J Surg Oncol. 62:1996;158-161.
13. Giuliano A.E., Kirgan D.M., Guenther J.M., et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 220:1994;391-401.
14. Giuliano A.E., Dale P.S., Turner R.R., et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 222:1995;394-401.
15. Krag D.N., Weaver D.L., Alex J.C., et al. Surgical resection and radio localization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 2:1993;335-339.